Discover 2,716 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,716
JoyPop Mobile Mental Health App With Transitional-Aged Youth
for
Emotion Regulation, Depression, Anxiety, Stress
Location: Thunder Bay
Sponsor: Lakehead University
Sex: All
Age: 18 - 25
Code: NCT06239545
Recruiting
The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments
Location: Scarborough ME, Boston MA, Montreal, Philadelphia PA,
Sponsor: Turning Point Therapeutics, Inc.
Sex: All
Age: 0 - 25
Code: NCT04094610
Phase1, Phase2, Recruiting
Effect of peRiopErative duLoxetIne Administration on Opioid Consumption Following Total kneE Arthroplasty (RELIFE)
for
Knee Osteoarthritis
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 50+
Code: NCT06423716
Recruiting
Therapeutic Relevance of Abnormal Airway Morphology in Asthma
for
Asthma
Location: Hamilton
Sponsor: McMaster University
Sex: All
Age: 18+
Code: NCT06970080
Recruiting
A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas
for
Sarcoma
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT07014137
Phase2, Recruiting
Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy
for
Mantle Cell Lymphoma
Location: Toronto, Vancouver
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT07341191
Phase2, Recruiting
FES Cycling With BFR in the Spinal Cord Injury Population
for
Spinal Cord Injury, Cardio Vascular Disease,
Location: Toronto
Sponsor: Dr. B. Catharine. Craven
Sex: All
Age: 18 - 70+
Code: NCT07588503
Phase1, Recruiting
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
for
Primary Hyperaldosteronism
Location: Montreal, Ottawa, Toronto, Columbia SC, Chicago IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07007793
Phase3, Recruiting
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
for
CLL, Chronic Lymphocytic Leukemia
Location: Shirley NY, Westbury NY, New York NY, Greenfield Park,